The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Mechanisms of protein-folding diseases at a glance
Open accessAbstract
For a protein to function appropriately, it must first achieve its proper conformation and location within the crowded environment inside the cell. Multiple chaperone systems are required to fold proteins correctly. In addition, degradation pathways participate by destroying improperly folded proteins. The intricacy of this multisystem process provides many opportunities for error. Furthermore, mutations cause misfolded, nonfunctional forms of proteins to accumulate. As a result, many pathological conditions are fundamentally rooted in the protein-folding problem that all cells must solve to maintain their function and integrity. Here, to illustrate the breadth of this phenomenon, we describe five examples of protein-misfolding events that can lead to disease: improper degradation, mislocalization, dominant-negative mutations, structural alterations that establish novel toxic functions, and amyloid accumulation. In each case, we will highlight current therapeutic options for battling such diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“Indeed, antibodies have recently been developed that generically recognize both amyloid fibrils and toxic oligomers, and it has been shown that an oligomerspecific antibody blocks the toxicity of multiple types of oligomers in vitro (Kayed et al., 2003; Glabe, 2004).”
BackgroundMolecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 4×
“These compounds prevent MDM2 from interacting with and promoting degradation of WT p53, increasing the probability of forming WT, functional tetramers (Vassilev et al., 2004).”
BackgroundInfluentialLuk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
The Protein-Folding Problem, 50 Years On
Dill, K. A., & MacCallum, J. L. (2012) · Science · doi:10.1126/science.1219021 · Cited by 1,699
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
The mechanism of Z α1-antitrypsin accumulation in the liver
Lomas, D. A., LI-Evans, D., Finch, J. T., & Carrell, R. W. (1992) · Nature · doi:10.1038/357605a0 · Cited by 1,053
INGRAM, V. M. (1957) · Nature · doi:10.1038/180326a0 · Cited by 978
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Potential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M., & Cyr, D. M. (2001) · Nature Cell Biology · doi:10.1038/35050509 · Cited by 839
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795
Protective effects of the sickle cell gene against malaria morbidity and mortality
Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., & Udhayakumar, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08273-9 · Cited by 700
Iba, M., Guo, J. L., McBride, J. D., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2642-12.2013 · Cited by 664
Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum
Smith, M. H., Ploegh, H. L., & Weissman, J. S. (2011) · Science · doi:10.1126/science.1209235 · Cited by 647
Phenotype, diagnosis, and treatment of Gaucher's disease
Grabowski, G. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61522-6 · Cited by 634
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
Hidvegi, T., Ewing, M., Hale, P., Dippold, C., Beckett, C., Kemp, C., Maurice, N., Mukherjee, A., Goldbach, C., Watkins, S., et al. (2010) · Science · doi:10.1126/science.1190354 · Cited by 607
Hsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis
Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson, J., Plutner, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.043 · Cited by 601
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Protein aggregation in crowded environments
Ellis, R. J., & Minton, A. P. (2006) · Biological Chemistry · doi:10.1515/bc.2006.064 · Cited by 421
Heat-shock protein hsp90 governs the activity of pp60v-src kinase.
Xu, Y., & Lindquist, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7074 · Cited by 416
Self-citationAutophagy and the ubiquitin-proteasome system: Collaborators in neuroprotection
Nedelsky, N. B., Todd, P. K., & Taylor, J. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.002 · Cited by 351
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
Ron, I., & Horowitz, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi240 · Cited by 330
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320
Human Apolipoprotein E4 Domain Interaction
Dong, L.-M., & Weisgraber, K. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19053 · Cited by 318
The Ubiquitin System, an Immense Realm
Varshavsky, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051910-094049 · Cited by 277
Sekijima, Y., Dendle, M. A., & Kelly, J. W. (2006) · Amyloid · doi:10.1080/13506120600960882 · Cited by 268
The p53 protein is an unusually shaped tetramer that binds directly to DNA.
Friedman, P. N., Chen, X., Bargonetti, J., & Prives, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3319 · Cited by 264
Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency
Maestri, N. E., Brusilow, S. W., Clissold, D. B., & Bassett, S. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351204 · Cited by 258
Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of -Amyloid
Nath, S., Agholme, L., Kurudenkandy, F. R., Granseth, B., Marcusson, J., & Hallbeck, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0615-12.2012 · Cited by 244
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.
Milner, J., Medcalf, E. A., & Cook, A. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.12 · Cited by 243
Hidvegi, T., Schmidt, B. Z., Hale, P., & Perlmutter, D. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508652200 · Cited by 241
Lalazar (1989) · doi:10.1016/s0021-9258(18)81806-3 · Cited by 238
Small molecule induced reactivation of mutant p53 in cancer cells
Liu, X., Wilcken, R., Joerger, A. C., Chuckowree, I. S., Amin, J., Spencer, J., & Fersht, A. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt305 · Cited by 234
Razavi, H., Palaninathan, S. K., Powers, E. T., Wiseman, R. L., Purkey, H. E., Mohamedmohaideen, N. N., Deechongkit, S., Chiang, K. P., Dendle, M. T. A., Sacchettini, J. C., et al. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351179 · Cited by 232
The cellular pathology of lysosomal diseases
Cox, T. M., & Cachón‐González, M. B. (2012) · The Journal of Pathology · doi:10.1002/path.3021 · Cited by 221
Chen, H.-K., Ji, Z.-S., Dodson, S. E., Miranda, R. D., Rosenblum, C. I., Reynolds, I. J., Freedman, S. B., Weisgraber, K. H., Huang, Y., & Mahley, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151084 · Cited by 209
Lindquist, S. L., & Kelly, J. W. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004507 · Cited by 190
Self-citationKeratin gene mutations in disorders of human skin and its appendages
Chamcheu, J. C., Siddiqui, I. A., Syed, D. N., Adhami, V. M., Liovic, M., & Mukhtar, H. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.019 · Cited by 186
Xu, Y., Singer, M. A., & Lindquist, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.109 · Cited by 184
Self-citationGaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles
Sawkar, A. R., Adamski-Werner, S. L., Cheng, W.-C., Wong, C.-H., Beutler, E., Zimmer, K.-P., & Kelly, J. W. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.09.007 · Cited by 183
Protein Homeostasis and the Phenotypic Manifestation of Genetic Diversity: Principles and Mechanisms
Jarosz, D. F., Taipale, M., & Lindquist, S. (2010) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090412 · Cited by 179
Self-citationAmyloid deposits: Protection against toxic protein species?
Treusch, S., Cyr, D., & Lindquist, S. L. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8503 · Cited by 163
Self-citationStructure-based design of conformation- and sequence-specific antibodies against amyloid β
Perchiacca, J. M., Ladiwala, A. R. A., Bhattacharya, M., & Tessier, P. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111232108 · Cited by 159
Conformation-dependent antibodies target diseases of protein misfolding
Glabe, C. C. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.08.009 · Cited by 156
Qu, B.-H., Strickland, E., & Thomas, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15739 · Cited by 139
Mallya, M., Phillips, R. L., Saldanha, S. A., Gooptu, B., Brown, S. C. L., Termine, D. J., Shirvani, A. M., Wu, Y., Sifers, R. N., Abagyan, R. A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070687z · Cited by 128
Taipale, M., Krykbaeva, I., Whitesell, L. J., Santagata, S., Zhang, J., Liu, Q., Gray, N. S., & Lindquist, S. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2620 · Cited by 128
Self-citationConformational diseases: Looking into the eyes
Surguchev, A. A., & Surguchov, A. P. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.015 · Cited by 127
Therapeutic strategies to ameliorate lysosomal storage disorders – a focus on Gaucher disease
Sawkar, A. R., D’Haeze, W., & Kelly, J. W. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5437-0 · Cited by 126
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1×
“At least one copy of the APOE4 allele is found in 65-80% of individuals with Alzheimer’s disease (AD) (Farrer et al., 1997).”
BackgroundBrodbeck, J., McGuire, J., Liu, Z., Meyer-Franke, A., Balestra, M. E., Jeong, D.-E., Pleiss, M., McComas, C., Hess, F., Witter, D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217380 · Cited by 113
Russell, D., Andrews, P. D., James, J. L., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01407 · Cited by 110
Amyloid in neurodegenerative diseases: Friend or foe?
Wolfe, K. J., & Cyr, D. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.03.011 · Cited by 93
Bijlmakers, M.-J., & Marsh, M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1585 · Cited by 87
Chamcheu, J. C., Navsaria, H. A., Pihl-Lundin, I., Liović, M., Vahlquist, A., & Törmä, H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.93 · Cited by 83
A Terminal Peptide Sequence of Human Hæmoglobin?
Hunt, J. A., & Ingram, V. M. (1959) · Nature · doi:10.1038/184640b0 · Cited by 71
Inhibiting HSP90 to treat cancer: a strategy in evolution
Whitesell, L., Santagata, S., & Lin, N. U. (2012) · Current Molecular Medicine · doi:10.2174/156652412803306657 · Cited by 67
Small Molecules That Target Protein Misfolding
Gavrin, L. K., Denny, R. A., & Saiah, E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301182j · Cited by 57
Membrane Transport in Sickle Cell Disease
Gibson, J. S., & Ellory, J. C. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0515 · Cited by 55
Cited by
Neurodegenerative disease: models, mechanisms, and a new hope
Gitler, A. D., Dhillon, P., & Shorter, J. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030205 · Cited by 739
Mahul-Mellier, A.-L., Burtscher, J., Maharjan, N., Weerens, L., Croisier, M., Kuttler, F., Leleu, M., Knott, G. W., & Lashuel, H. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913904117 · Cited by 710
Protein Quality Control by Molecular Chaperones in Neurodegeneration
Ciechanover, A., & Kwon, Y. T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00185 · Cited by 346
The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis
Kolb, P. S., Ayaub, E. A., Zhou, W., Yum, V., Dickhout, J. G., & Ask, K. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.015 · Cited by 273
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Ajoolabady, A., Lindholm, D., Ren, J., & Pratico, D. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05153-5 · Cited by 261
Metadata
- Authors
- Valastyan, J. S., & Lindquist, S.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2014-01-01
- Volume
- 7
- Issue
- 1
- Pages
- 9-14
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2156098042
- Cited by
- 307
- References
- 69
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.